Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Schmidt-Wolf

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Hematotherapy|December 1, 1995
Bone marrow and clinical gene therapyG D Schmidt-Wolf, I G Schmidt-Wolf
Immunology Today|April 1, 1995
Cytokines and gene therapyG D Schmidt-Wolf, I G Schmidt-Wolf
Annals of Hematology|November 1, 1996
Cancer and gene therapyG D Schmidt-Wolf, I G Schmidt-Wolf
British Journal of Haematology|March 29, 2002
Immunomodulatory gene therapy for haematological malignanciesG D Schmidt-Wolf, I G H Schmidt-Wolf
Clinical and Experimental Medicine|May 16, 2003
Gene therapy for hematological malignanciesG D Schmidt-Wolf, I G H Schmidt-Wolf
Annals of Hematology|February 1, 1997
Activated T cells and cytokine-induced CD3+CD56+ killer cellsG D Schmidt-Wolf, R S Negrin, I G Schmidt-Wolf
Cancer Immunology, Immunotherapy : CII|January 6, 1999
Generation of cytokine-induced killer cells using exogenous interleukin-2, -7 or -12B Zoll, P Lefterova, M Csipai, et al.
Annals of Hematology|July 8, 2003
Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patientsH Goldschmidt, P Sonneveld, F W Cremer, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Hematotherapy|December 1, 1995
Bone marrow and clinical gene therapyG D Schmidt-Wolf, I G Schmidt-Wolf
Immunology Today|April 1, 1995
Cytokines and gene therapyG D Schmidt-Wolf, I G Schmidt-Wolf
Annals of Hematology|November 1, 1996
Cancer and gene therapyG D Schmidt-Wolf, I G Schmidt-Wolf
British Journal of Haematology|March 29, 2002
Immunomodulatory gene therapy for haematological malignanciesG D Schmidt-Wolf, I G H Schmidt-Wolf
Clinical and Experimental Medicine|May 16, 2003
Gene therapy for hematological malignanciesG D Schmidt-Wolf, I G H Schmidt-Wolf
Annals of Hematology|February 1, 1997
Activated T cells and cytokine-induced CD3+CD56+ killer cellsG D Schmidt-Wolf, R S Negrin, I G Schmidt-Wolf
Cancer Immunology, Immunotherapy : CII|January 6, 1999
Generation of cytokine-induced killer cells using exogenous interleukin-2, -7 or -12B Zoll, P Lefterova, M Csipai, et al.
Annals of Hematology|July 8, 2003
Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patientsH Goldschmidt, P Sonneveld, F W Cremer, et al.
Pageof 1